AE Wealth Management’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-39,250
Closed -$5.98K 2111
2023
Q2
$5.98K Sell
39,250
-200
-0.5% -$31 ﹤0.01% 1881
2023
Q1
$5.66K Hold
39,450
﹤0.01% 1860
2022
Q4
$4.73K Sell
39,450
-1,000
-2% -$144 ﹤0.01% 1807
2022
Q3
$7K Sell
40,450
-25
-0.1% -$13 ﹤0.01% 1731
2022
Q2
$72K Buy
40,475
+500
+1% +$1.12K ﹤0.01% 1657
2022
Q1
$120K Hold
39,975
﹤0.01% 1605
2021
Q4
$149K Sell
39,975
-1,625
-4% -$9.51K ﹤0.01% 1620
2021
Q3
$247K Buy
41,600
+3,200
+8% +$45K ﹤0.01% 1442
2021
Q2
$667K Buy
38,400
+16,400
+75% +$299K 0.01% 1011
2021
Q1
$420K Buy
+22,000
New +$402K ﹤0.01% 1102

Other funds holding HGEN

AE Wealth Management's HGEN Position: Q3 2023 in Review

AE Wealth Management sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 39,250 shares — an estimated $5.98K sold.

AE Wealth Management first reported a position in HGEN in Q1 2021 and held it in 10 quarters. The position peaked at $667K in Q2 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

  • AE Wealth Management reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
  • AE Wealth Management sold 39,250 HUMANIGEN, INC. shares in Q3 2023, an estimated $5.98K.
  • AE Wealth Management first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 10 quarters.
  • AE Wealth Management's HUMANIGEN, INC. position peaked at $667K in Q2 2021.
  • 3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on AE Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.